On 20 November 2025, Regenix was recognised by Forbes India as part of the Select 200 Companies with Global Business Potential at the DGEMS 2025 forum, held at the Taj Palace, Diplomatic Enclave, New Delhi. The Select 200 is a curated annual cohort of Indian businesses identified by Forbes India and D Globalist as having the leadership, capability and market readiness to scale beyond domestic markets.
About the recognition
The Forbes India DGEMS programme is designed as a launchpad for borderless business — bringing together a peer group of high-potential Indian founders and connecting them with global investors, government representatives and senior regulatory, legal and business-acceleration experts from North America, the United Kingdom, Europe, the MENA region and Asia.
The 2025 cohort spans five archetypes — Creators, Enablers, Builders, Sustainers and Transformers — reflecting the diversity of Indian businesses building beyond domestic markets.
Select 200 of DGEMS 2025 — a curated group of 200 Indian companies identified by Forbes India as having the leadership, capability and market readiness to grow beyond domestic markets.
What it means for Regenix
For Regenix — a Chennai-based biosimilar manufacturer with active exports across four regions (South-East Asia, Africa, Latin America and Middle East & CIS) — the recognition affirms the company's positioning as a high-potential Indian biopharma poised for further international scale.
With four CDSCO Marketing Authorisations across the diabetes franchise, an eight-product biosimilar portfolio spanning diabetes, obesity and anticoagulation, and a pipeline targeting 120+ markets by 2028, Regenix continues to invest in regulatory infrastructure, manufacturing capability and partnership engagements across high-growth regions.
The DGEMS 2025 forum
The November 20 forum brought together the Select 200 founders alongside global VCs, government representatives and a Global Expansion Pavilion staffed by country experts — enabling structured one-on-one meetings to explore market entry pathways, regulatory requirements and partnership opportunities.
Forbes India announced the full Select 200 cohort across its website and social channels in November 2025.
Looking forward
Regenix views the DGEMS recognition as the beginning of a longer engagement — with the magazine publication, ongoing peer collaboration and the Select 200 community activities planned through 2026 — rather than a one-off accolade. The company will continue to share updates on its international expansion roadmap, regulatory milestones and partnership engagements through this newsroom.